Financhill
Back

TransMedics Group 10K Form

Sell
41

TMDX
TransMedics Group

Last Price:
$69.07
Seasonality Move:
18.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $441.5M
Cash Flow: $6.1M
Price / Cash Flow: 0
Annual Sales: $6.80
Price / Book: 10.14

Profitability

EPS (TTM): 1.01000
Net Income (TTM): $35.5M
Gross Margin: $262.1M
Return on Equity: 19.17%
Return on Assets: 4.69%

TransMedics Group Earnings Forecast

Key TransMedics Group Financial Ratios

  • The Gross Profit Margin over the past 9 years for TMDX is 59.36%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 38.19% of Gross Profit Margin.
  • The Research & Development expenses have been 12.68% of Revenue.
  • The Interest Expense is 40.63% of Operating Income.
  • The Net Earning history of TMDX is 8.03% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 6 years.

TransMedics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 2.23
Current Ratio: 8.3
Quick Ratio: 7.25

Price-to-Earnings

Trailing P/E Ratio: 64.34
Forward P/E Ratio: 30.79

TMDX Technical Analysis vs Fundamental Analysis

Sell
41
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy or a Sell?

  • TransMedics Group stock is rated a Sell
    The current TransMedics Group [TMDX] share price is $68.84. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.